Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Liposomes could improve how skin care products work but are costly and not very stable.

Researchers identified genes linked to coat color, body size, cashmere production, and high altitude adaptation in goats.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Some medications can cause acne, and stopping these drugs is the main treatment.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Asian hair is generally straight and thick, with unique disorders and properties, and more research is needed to understand it fully.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Type I interferons play a key role in the development of various skin diseases.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Ultrasound is a useful, non-invasive tool in dermatology for diagnosing skin conditions and guiding treatments, but it has some limitations.